Zeuthen J - Search Results

1

Accumulation of identical T cells in melanoma and vitiligo-like leukoderma.

Becker JC, Guldberg P, Zeuthen J, Bröcker EB, Straten PT. Becker JC, et al. Among authors: zeuthen j. J Invest Dermatol. 1999 Dec;113(6):1033-8. doi: 10.1046/j.1523-1747.1999.00805.x. J Invest Dermatol. 1999. PMID: 10594748

2

Comparative delineation of T cell clonotypes in coexisting syngeneic B16 melanoma.

Moerch U, Schrama D, Guldberg P, Seremet T, Zeuthen J, Becker JC, thor Straten P. Moerch U, et al. Among authors: zeuthen j. Cancer Immunol Immunother. 2000 Oct;49(8):426-32. doi: 10.1007/s002620000136. Cancer Immunol Immunother. 2000. PMID: 11043849

3

In situ T cells in melanoma.

thor Straten P, Becker JC, Guldberg P, Zeuthen J. thor Straten P, et al. Among authors: zeuthen j. Cancer Immunol Immunother. 1999 Oct;48(7):386-95. doi: 10.1007/s002620050591. Cancer Immunol Immunother. 1999. PMID: 10501852 Review.

4

Establishment of gp100 and MART-1/Melan-A-specific cytotoxic T lymphocyte clones using in vitro immunization against preselected highly immunogenic melanoma cell clones.

Kirkin AF, thor Straten P, Hansen MR, Barfoed A, Dzhandzhugazyan KN, Zeuthen J. Kirkin AF, et al. Among authors: zeuthen j. Cancer Immunol Immunother. 1999 Aug;48(5):239-46. doi: 10.1007/s002620050571. Cancer Immunol Immunother. 1999. PMID: 10478640

5

Clonal T cell responses in tumor infiltrating lymphocytes from both regressive and progressive regions of primary human malignant melanoma.

thor Straten P, Becker JC, Seremet T, Bröcker EB, Zeuthen J. thor Straten P, et al. Among authors: zeuthen j. J Clin Invest. 1996 Jul 15;98(2):279-84. doi: 10.1172/JCI118790. J Clin Invest. 1996. PMID: 8755635 Free PMC article.

6

Mutation and allelic loss of the PTEN/MMAC1 gene in primary and metastatic melanoma biopsies.

Birck A, Ahrenkiel V, Zeuthen J, Hou-Jensen K, Guldberg P. Birck A, et al. Among authors: zeuthen j. J Invest Dermatol. 2000 Feb;114(2):277-80. doi: 10.1046/j.1523-1747.2000.00877.x. J Invest Dermatol. 2000. PMID: 10651986

7

In situ T cell responses against melanoma comprise high numbers of locally expanded T cell clonotypes.

thor Straten P, Guldberg P, Grønbaek K, Hansen MR, Kirkin AF, Seremet T, Zeuthen J, Becker JC. thor Straten P, et al. Among authors: zeuthen j. J Immunol. 1999 Jul 1;163(1):443-7. J Immunol. 1999. PMID: 10384147

8

Melanoma-associated antigens recognized by cytotoxic T lymphocytes.

Kirkin AF, Dzhandzhugazyan K, Zeuthen J. Kirkin AF, et al. Among authors: zeuthen j. APMIS. 1998 Jul;106(7):665-79. doi: 10.1111/j.1699-0463.1998.tb00210.x. APMIS. 1998. PMID: 9740504 Review.

9

T-cell receptor variable region genes in cutaneous T-cell lymphomas.

Thor Straten P, Ralfkiaer E, Hendriks J, Seremet T, Vejlsgaard GL, Zeuthen J. Thor Straten P, et al. Among authors: zeuthen j. Br J Dermatol. 1998 Jan;138(1):3-12. doi: 10.1046/j.1365-2133.1998.02022.x. Br J Dermatol. 1998. PMID: 9536217

10

Analysis of T cell receptor alpha beta variability in tumor-infiltrating lymphocytes in primary and metastatic melanoma.

Zeuthen J, Birck A, Straten PT. Zeuthen J, et al. Arch Immunol Ther Exp (Warsz). 1995;43(2):123-33. Arch Immunol Ther Exp (Warsz). 1995. PMID: 8744727

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results